Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,724 | -65,857 | -44,085 | -20,565 | 7,167 |
| Depreciation Amortization | 2,071 | 1,393 | 950 | 432 | 3,882 |
| Accounts receivable | 229 | 225 | 229 | 225 | 672 |
| Accounts payable and accrued liabilities | -737 | 313 | 93 | -106 | -2,096 |
| Other Working Capital | -24,708 | -2,495 | -4,380 | -1,759 | -55,989 |
| Other Operating Activity | 3,026 | 11,828 | 7,870 | 2,721 | -12,081 |
| Operating Cash Flow | $-65,843 | $-54,593 | $-39,323 | $-19,052 | $-58,445 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -44 | -61 | -64 | -190 |
| Purchase Sale Intangibles | -615 | -265 | -265 | -250 | -25 |
| Other Investing Activity | -615 | -265 | -265 | -250 | -25 |
| Investing Cash Flow | $-634 | $-309 | $-326 | $-314 | $-215 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 22,468 |
| Common Stock Issued | 95,162 | 17,646 | 15,987 | 10,687 | 50,487 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -22,505 |
| Financing Cash Flow | $95,162 | $17,646 | $15,987 | $10,687 | $50,450 |
| Beginning Cash Position | 108,468 | 108,468 | 108,468 | 108,468 | 116,678 |
| End Cash Position | 137,153 | 71,212 | 84,806 | 99,789 | 108,468 |
| Net Cash Flow | $28,685 | $-37,256 | $-23,662 | $-8,679 | $-8,210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,843 | -54,593 | -39,323 | -19,052 | -58,445 |
| Capital Expenditure | -85 | -66 | -66 | -64 | -250 |
| Free Cash Flow | -65,928 | -54,659 | -39,389 | -19,116 | -58,695 |